Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

Ellison, George T. H., Kaufman, Jay S., Head, Rosemary F., Martin, Paul A. and Kahn, Jonathan D. (2008) Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients. The Journal of Law Medicine & Ethics, 36(3), pp. 449-457. ISSN (print) 1073-1105

Full text not available from this archive.
Item Type: Article
Research Area: Social work and social policy and administration
Faculty, School or Research Centre: Faculty of Health and Social Care Sciences
Depositing User: Lucinda Lyon
Date Deposited: 22 Apr 2009 09:21
Last Modified: 26 Jul 2010 10:18
URI: http://eprints.kingston.ac.uk/id/eprint/4655

Actions (Repository Editors)

Item Control Page Item Control Page